HU Group Holdings specializes in biotechnology services and products, focusing on diagnostics, research, and life sciences. They cater primarily to medical professionals, research institutions, and healthcare providers.
2024 Revenue: Estimated $450 million
Employees: 1,200
HU Group Holdings is one of the...
HU Group Holdings is a company listed under the stock ticker 4544 (JP).
HU Group Holdings has a direct presence in 4 countries.HU Group Holdings has 5 subsidiaries including Fujirebio, Fujirebio Diagnostics and Fujirebio Diagnostics Europe.
They are in:
View the org chart displaying its 54 main executives
Create your alert
to follow the executive moves at HU Group Holdings.
HU Group Holdings has 2,340 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.